This review summarizes the changes in the 5th edition of the WHO Classification of
Endocrine and Neuroendocrine Tumors that relate to the thyroid gland. The new …

The impact of BRAF mutations on the clinical outcomes of PTC remains debatable. In ATCs,
in turn, BRAF mutations identify patients eligible for targeted therapy, which is now …

Background: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features
(NIFTP) reclassification has significantly influenced the field of thyroidology. However, the …

The most common BRAF mutation is thymine (T) to adenine (A) missense mutation in
nucleotide 1796 (T1796A, V600E). The BRAFV600E gene encodes a protein-dependent …

Diffuse sclerosing variant papillary thyroid carcinoma (DS-PTC) is characterized clinically by
a predilection for children and young adults, bulky neck nodes, and pulmonary metastases …

Thyroid cancer (TC) is the most frequent endocrine malignancy. The incidence of TC,
especially papillary thyroid carcinoma (PTC), has continued to rise all over the world during …

Simple Summary Histopathological diagnosis is prone to significant observer variation in the
diagnosis of papillary thyroid carcinomas (PTCs) due to different thresholds of malignancy …

Background: The criteria for determining technical efficacy of thermal ablation for papillary
thyroid carcinoma (PTC) are not clearly defined. We analyzed the involution process of the …

Background Previous literatures showed wide range of prevalence of BRAF V600E in
papillary thyroid carcinoma (PTC). The correlation of BRAF V600E mutation with aggressive …

Objectives Artificial intelligence (AI) systems can diagnose thyroid nodules with similar or
better performance than radiologists. Little is known about how this performance compares …